Funder: National Institutes of Health
Due Dates: September 29, 2026 (Forecasted)
Funding Amounts: Up to $15,000,000 total; 1 expected award; cooperative agreement
Summary: Supports a clinical research network focused on advancing research and clinical solutions for antimicrobial resistance (AMR), especially for bacterial and fungal infections.
Key Information: No cost sharing required; single large-scale award anticipated.